Werbung
Werbung

ANGO

ANGO logo

AngioDynamics, Inc.

9.84
USD
Gesponsert
-0.21
-2.05%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

9.89

+0.05
+0.47%

ANGO Ergebnisberichte

Positives Überraschungsverhältnis

ANGO übertreffen die 28 der letzten 40Schätzungen.

70%

Nächster Bericht

Datum des nächsten Berichts
31. März 2026
Estimate for Q3 26 (Revenue/ EPS)
$78.40M
/
-$0.09
Implizierte Änderung von Q2 26 (Revenue/ EPS)
-1.29%
/
--
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+8.89%
/
-400.00%

AngioDynamics, Inc. earnings per share and revenue

On 06. Jan. 2026, ANGO reported earnings of 0.00 USD per share (EPS) for Q2 26, beating the estimate of -0.10 USD, resulting in a 100.00% surprise. Revenue reached 79.43 million, compared to an expected 77.83 million, with a 2.06% difference. The market reacted with a -13.53% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 78.40 million USD, implying an -- of --% EPS, and decrease of -1.29% in Revenue from the last quarter.
FAQ
For Q2 2026, AngioDynamics, Inc. reported EPS of $0.00, beating estimates by 100%, and revenue of $79.43M, 2.06% above expectations.
The stock price moved down -13.53%, changed from $13.23 before the earnings release to $11.44 the day after.
The next earning report is scheduled for 31. März 2026.
Based on 6 analysts, AngioDynamics, Inc. is expected to report EPS of -$0.09 and revenue of $78.40M for Q3 2026.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung